WEIGHT LOSS MANAGEMENT

Both medications were originally developed to treat type 2 diabetes. However, given their efficacy in promoting weight loss, both have gained more widespread use for losing weight.

While these medications have similarities, the main difference is that Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor substance, while Semaglutide is a glucagon-like peptide 1 receptor receptor.

Tirzepatide works by controlling blood sugar and slowing down digestion. This causes the user to feel full faster.

Semaglutide works by suppressing the user’s appetite, leaving them to eat less food and stimulating weight loss.

Several studies have found that Tirzepatide produces more significant results than Semaglutide — this is likely because Tirzepatide is a dual substance compared to Semaglutide.

While Tirzepatide may be more effective for some, Semaglutide has been around for a longer period and is more widely used.

Because of this, it may be easier to gain access to a Semaglutide prescription. In addition, there are more studies on the long-term results and effectiveness of Semaglutide compared to Tirzepatide.

Your doctor may also recommend one over the other based on your medical history.

We suggest you call your insurance company to determine if these medications are covered. While some insurance plans may cover weight loss injections for treating diabetes, it’s less likely to be covered when used strictly for weight loss.

For Tirzepatide, weight loss results tend to become noticeable around four to six weeks after starting injections.

For Semaglutide, results can become noticeable between four to 12 weeks after starting injections.

Please note that results vary depending on the individual.

For both medications, you may regain the weight lost once you fully stop taking the injections.

Your doctor will most likely start you off with a higher dose of injections, which may taper off to be less frequent once results take effect.